# Diagnostic Value of Sonazoid Contrast-enhanced Ultrasound in Renal Tumors

> **NCT04626115** · — · UNKNOWN · sponsor: **Chinese PLA General Hospital** · enrollment: 223 (estimated)

## Conditions studied

- Contrast Enhanced Ultrasound

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04626115
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-01
- **Primary completion:** 2021-03
- **Final completion:** 2021-08
- **Target enrollment:** 223 (ESTIMATED)
- **Last updated:** 2020-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04626115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04626115, "Diagnostic Value of Sonazoid Contrast-enhanced Ultrasound in Renal Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04626115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*